However, gaps in our knowledge remain on the interactions between these three factors in cancer progression, whether or not the metastatic site influences their expression and activity, and which STMN1 phosphoserines regulate PCa cell cycle progression, proliferation, and/or metastatic potential in response to HGF/MET signaling. The gene discussed is MET; the disease is cancer.